alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › dual-glp-1

dual-glp-1

3 studies tagged dual-glp-1, dated 2019-11-28 to 2025-05-08. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model 2025-05-08
  2. A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson's Disease 2023-09-25
  3. A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice 2019-11-28

Studies

3 studies carry this tag.

Date range

2019 to 2025

Top journals

  • Hormones and behavior 1
  • Molecular neurobiology 1
  • Parkinson's disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Molecular neurobiology 2025-05-08 Drug development

    Glucagon-like peptide 1 (GLP-1) is a peptide hormone and growth factor.

  2. A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson's Disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Parkinson's disease 2023-09-25 Drug development

    Parkinson's disease (PD) is a complex syndrome with many elements, such as chronic inflammation, oxidative stress, mitochondrial dysfunction, loss of dopaminergic neurons, build-up of alpha-synuclein ( α -syn) in cells, and energy depletion in neurons, that drive the disease.

  3. A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Hormones and behavior 2019-11-28 Drug development

    Alzheimer's disease (AD) is a neurodegenerative disease that severely affects the health and lifespan of the elderly worldwide.

All topic tags with their study counts